Skip to main content
Addgene

pGL2-Mcl-1 mut
(Plasmid #19133)

Print

Ordering

This material is available to academics and nonprofits only.
Item Catalog # Description Quantity Price (USD)
Plasmid 19133 Standard format: Plasmid sent in bacteria as agar stab 1 $85
Add to Cart

Backbone

  • Vector backbone
    pGL2-basic
  • Backbone size w/o insert (bp) 5597
  • Vector type
    Mammalian Expression, Luciferase

Growth in Bacteria

  • Bacterial Resistance(s)
    Ampicillin, 100 μg/mL
  • Growth Temperature
    37°C
  • Growth Strain(s)
    DH5alpha
  • Copy number
    Unknown

Gene/Insert

  • Gene/Insert name
    Mcl-1 promoter
  • Species
    H. sapiens (human)
  • Insert Size (bp)
    325
  • Mutation
    NFkB binding-site mutant, the sequence GGGGTCTTCC in the NFkB-3 region was changed to GTTGTCTTCC.
  • Entrez Gene
    MCL1 (a.k.a. BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1, TM, bcl2-L-3, mcl1/EAT)

Cloning Information

Resource Information

Terms and Licenses

Trademarks:
  • Zeocin® is an InvivoGen trademark.
How to cite this plasmid ( Back to top)

These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.

  • For your Materials & Methods section:

    pGL2-Mcl-1 mut was a gift from Wafik El-Deiry (Addgene plasmid # 19133 ; http://n2t.net/addgene:19133 ; RRID:Addgene_19133)

  • For your References section:

    Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Ricci MS, Kim SH, Ogi K, Plastaras JP, Ling J, Wang W, Jin Z, Liu YY, Dicker DT, Chiao PJ, Flaherty KT, Smith CD, El-Deiry WS. Cancer Cell. 2007 Jul . 12(1):66-80. 10.1016/j.ccr.2007.05.006 PubMed 17613437
Related items:
Commonly requested with: